GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palatin Technologies Inc (FRA:PTN) » Definitions » Loans Receivable

Palatin Technologies (FRA:PTN) Loans Receivable : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Palatin Technologies Loans Receivable?

Palatin Technologies's Loans Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.


Palatin Technologies Loans Receivable Historical Data

The historical data trend for Palatin Technologies's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palatin Technologies Loans Receivable Chart

Palatin Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Palatin Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Palatin Technologies Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Palatin Technologies Loans Receivable Related Terms

Thank you for viewing the detailed overview of Palatin Technologies's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Palatin Technologies Business Description

Traded in Other Exchanges
Address
4B Cedar Brook Drive, Cranbury, NJ, USA, 08512
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.